about
Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patientsModulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoidsAgents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair.Accessing NCI's SEER cancer data base with SeerQuery and CD-ROM.Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology Group.Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.Cancer screening in older adults.Tumors of the kidney, ureter, and bladderOn cancer control and the adolescentProliferative and apoptotic responses in cancers with special reference to oral cancer.Pattern of testicular biopies as seen in a tertiary institution in nnewi, southeast NigeriaTime Trends of Gastro-esophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD) in IranA role for inflammatory mediators in the induction of immunoregulatory B cellsInhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone.Oral cancer: risk factors and molecular pathogenesisRecent results in animal models of pancreatic carcinoma: histogenesis of tumors.Opposing time trends of peptic ulcer and reflux disease.Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.Psychological interventions for cancer patients to enhance the quality of life.Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor.Interphase molecular cytogenetic analysis of epithelial ovarian carcinomasDetection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude miceAn examination of obesity and breast cancer survival in post-menopausal women.Palliative care for patients with advanced cancer.Imaging of lumps and bumps in the nose: a review of sinonasal tumours.Colon cancer in the elderly: evidence for major improvements in health care and survivalA dose-finding study of carboplatin-epirubicin-docetaxel in advanced epithelial ovarian cancer.Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species.Diagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinomaThe integration of HPV-18 DNA in cervical carcinoma.Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis.Chemopreventive potential of 3-[2,6-bis(4-fluorophenyl)-3-methylpiperidin-4-ylideneamino]-2-thioxoimidazolidin-4-one on 7,12-dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinogenesis.Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.Antiproliferative Effects of Red and White Wine Extracts in PC-3 Prostate Cancer Cells.A multiparametric approach to improve upon existing prostate cancer screening and biopsy recommendations.Oncologic reconstruction: General principles and techniques.Value of prostate cancer screening in a comprehensive community cancer center.Effects of phenolic compounds isolated from Rabdosia japonica on B16-F10 melanoma cells.Identification of risk factors in patients treated for first relapse of Hodgkin's disease.
P2860
Q28346039-9041B419-B880-4967-AA5B-4AABF630677CQ28373493-A394ED0E-3666-453B-9BBA-F63C033ADB95Q30875806-2971B9D9-3226-4E3B-B2D6-F4446FDCB579Q31029758-D033A889-6ACC-443C-86FF-485E1198E92AQ33364471-7AF1BEDD-7882-420F-9E51-1600A0F4E9D8Q33497942-2BF38B51-6452-4A63-A786-5F169CA5E857Q33560219-DA9C279D-39BC-4571-9FC4-1C3985057B3CQ33560238-84DBA731-DEA6-47C7-BA53-6E05E413254AQ33652428-FD25D7B4-6B1D-40F5-B360-1EDDD673CC4EQ33888373-38C37A7B-592A-4C77-8852-2B77ED1B37D1Q34077551-15536818-75C5-43FD-AF9A-287CB2681C13Q34134497-3BEC48E0-4713-4FA9-AC1F-CE9BE17743BCQ35053422-8D644CE2-958A-4227-B279-0EB757BFCCB0Q35068355-16B39D6F-9A3E-4EF8-BE85-270C411560C0Q35224923-3E3FEF71-4FF2-452A-ACF4-40396BDC301DQ35241617-3662EF1E-6B65-4844-B287-0A509BA6270FQ35352354-9B9F18B0-0AC2-45F1-8ECC-9E60348297C5Q35614963-8A7B3C9A-9D9E-425B-8713-8E92EB182533Q35738556-2362FF8F-3646-4A58-9C8E-02195676F903Q35768659-BC1AFF05-94F6-4F8D-84EA-A3E6B71448B4Q35832435-4F85EED2-C168-4B28-BB55-1E0B517C5903Q35833088-5F9398EA-D598-4399-93D2-7166AC9E36BCQ36080188-135BB18C-EF84-464B-96FF-3070A3827120Q36080305-975E3803-6D51-462C-A45C-DCB51B070B19Q36218947-92A4F69B-1DDF-4BFC-BB8D-4C0C930BBC03Q36345360-3EE37585-4F1F-4122-AC74-E4E4D86AAE11Q36431164-44907644-DE64-40E7-BCDA-042CBFE1A10DQ36644381-B9F17641-5396-49AA-A584-8B780D53D90AQ37361204-E1672347-83F2-415F-82D0-EED1851E17E2Q37417963-FA8AE513-2EEC-42D8-8ABA-C4209FA8BA10Q37642400-3AD33A38-16A8-4EE8-A3AF-3CADA96EAD5CQ38363316-5AEB9430-D3BB-4F31-BEF4-B707DE6E264CQ38445544-AAFE8CB6-97BC-48F9-9C5D-407B264F149EQ38490645-BAE01918-75CB-48B3-9974-A1BEDC160516Q38662424-639944DE-EECB-4879-B717-5656A19A7152Q38725930-478443DB-FEE7-4801-9408-3EDECE439620Q38759410-6CC00C5D-7E04-4D0B-9A06-063EF12EFB99Q39370486-B04C60F8-335E-4C82-B685-3C9F7CC1A37AQ39970178-6E892547-6CB4-4C5A-A4D5-02B894A2F48FQ40599134-7C4FC181-3FFC-4B9B-ABD2-D74761B420C7
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Cancer statistics, 1992.
@en
Cancer statistics, 1992.
@nl
type
label
Cancer statistics, 1992.
@en
Cancer statistics, 1992.
@nl
prefLabel
Cancer statistics, 1992.
@en
Cancer statistics, 1992.
@nl
P2093
P356
P1433
P1476
Cancer statistics, 1992.
@en
P2093
P356
10.3322/CANJCLIN.42.1.19
P407
P577
1992-01-01T00:00:00Z